Nippon India Pharma Fund Direct Growth

Equity
Sectoral
Very High Risk
01234567890123456789.01234567890123456789%
3Y annualised
-1.05% 1D
1M
6M
1Y
3Y
5Y
All
NAV: 26 Mar 2025₹537.43
Min. SIP amount₹100
Rating3
Fund size₹7,637.04Cr

Return calculator

Monthly SIP
One-Time
₹5,000 per month
Over the past
1 year
3 years
5 years
Total investment of ₹60,000
Would have become ₹58,691 (-2.18%)

Holdings (36)

NameSectorInstrumentAssets
HealthcareEquity13.68%
HealthcareEquity9.32%
HealthcareEquity7.73%
HealthcareEquity5.90%
HealthcareEquity5.35%
HealthcareEquity5.14%
HealthcareEquity3.82%
HealthcareEquity3.41%
HealthcareEquity3.39%
HealthcareEquity3.28%
HealthcareEquity3.12%
HealthcareEquity3.11%
HealthcareEquity2.84%
HealthcareEquity2.36%
HealthcareEquity2.30%
HealthcareEquity2.15%
HealthcareEquity1.95%
HealthcareEquity1.94%
HealthcareEquity1.69%
HealthcareEquity1.69%
HealthcareEquity1.59%
HealthcareEquity1.51%
HealthcareEquity1.39%
HealthcareEquity1.33%
HealthcareEquity1.27%
HealthcareEquity1.22%
HealthcareEquity1.09%
HealthcareEquity0.96%
HealthcareEquity0.90%
HealthcareEquity0.87%
HealthcareEquity0.62%
HealthcareEquity0.56%
HealthcareEquity0.47%
HealthcareEquity0.39%
HealthcareEquity0.32%
HealthcareEquity0.22%
See All

Minimum investment amounts

Min. for 1st investment₹5,000
Min. for 2nd investment onwards₹1,000
Min. for SIP₹100

Returns and rankings

Category: Equity Sectoral
Annualised returns
Absolute returns
1Y3Y5YAll
Fund returns15.1%19.8%29.8%18.1%
Category average19.1%18.8%28.2%NA
Rank with in category1054NA
Understand terms

Expense ratio, exit load and tax

Expense ratio: 0.91%

Inclusive of GST

Exit load

Exit load of 1% if redeemed within 1 month.

Stamp duty

0.005% (from July 1st, 2020)

Tax implication

Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.

Understand terms
Check past data

Fund management

Sailesh Raj Bhan
Jan 2013 - Present
View details

Education
Mr. Bhan is an MBA (Finance) and CFA.
Experience
Prior to joining Nippon India Mutual Fund, he has worked with Emkay Share & Stock Broker Pvt. Ltd, Shah & Sequeira Invst. Pvt. Ltd, ICFAI- Securities Research Center Analyst - Equity Research.
Also manages these schemes

Fund house & investment objective

Fund house contact details

Address
4th Floor, Tower A, Peninsula Business Park,Ganapatrao Kadam Marg, Lower Parel (W), Mumbai 400013
Phone
NA
Launch Date
30 Jun 1995
E-mail
NA
Website
Nippon India Mutual Fund
Asset Management Company
Custodian
Deutsche Bank
Registrar & Transfer Agent
KFin Tech
Address
Karvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,

Pros and cons

Category: Equity Sectoral

Pros

3Y, 5Y and 10Y annualised returns higher than category average
Lower expense ratio: 0.91%

Cons

1Y annualised returns lower than category average by 2.81%

Compare funds

Nippon India Pharma Fund Direct Growth
VS
Add mutual fund to compare
MONTHLY SIP
ONE-TIME
SIP Amount
₹
Monthly SIP Date
1st
Next SIP instalment on 27 of Mar
â“’ 2016-2025 Groww. All rights reserved, Built with ♥in India
MOST POPULAR ON GROWWVERSION - 5.9.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ